These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38430737)
1. Establishment of a transgene-free iPS cell line (SDCHi003-A) from a young patient bearing a NPRL2 mutation and suffering from Epilepsy. Su S; Zhao F; Zhang H; Liu Y; Li Z; Zhang H; Wang Y; Fang F; Liu Y Stem Cell Res; 2024 Apr; 76():103366. PubMed ID: 38430737 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a transgene-free iPS cell line (SDCHi008-A) from a young patient bearing a KCNQ2 mutation and suffering from Epilepsy. Zhang H; Zhang Q; Chen X; Wang M; Li L; Yu C Stem Cell Res; 2024 Oct; 80():103507. PubMed ID: 39079397 [TBL] [Abstract][Full Text] [Related]
3. Establishment of a transgene-free iPS cell line (SDCHi002-A) from a young patient bearing a NPRL3 mutation and suffering from Epilepsy. Su S; Ren Y; Zhang H; Liu Y; Liu Y; Li Z; Zhang T; Fang F Stem Cell Res; 2024 Oct; 81():103574. PubMed ID: 39426047 [TBL] [Abstract][Full Text] [Related]
4. Establishment of a transgene-free iPS cell line (SDQLCHi046-A) from a young patient bearing a HDAC8 mutation and suffering from Cornelia de Lange Syndrome. Li Z; Liu C; Xin H; Yang Y; Wang Y; Niu S; Gao C; Gai Z; Liu Y Stem Cell Res; 2023 Feb; 66():102984. PubMed ID: 36481505 [TBL] [Abstract][Full Text] [Related]
5. Establishment of a transgene-free iPS cell line (SDCHi007-A) from a young patient bearing a ATP1A2 mutation and suffering from Epilepsy. Zhang H; Zhang T; Wang Y; Shi J; Meng Y; Zhang Q; Guo Q; Duan C Stem Cell Res; 2024 Sep; 79():103490. PubMed ID: 39002250 [TBL] [Abstract][Full Text] [Related]
6. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A. Zhang Y; Li A; Huang CL; Wang G; Wang D Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203 [TBL] [Abstract][Full Text] [Related]
7. An achievement has been made in establishing an induced pluripotent stem cell line (SDPHi005-A) from a healthy Chinese male donor. Shao J; Jin Y; Shao C; Zhang X; Yang G Stem Cell Res; 2024 Jun; 77():103393. PubMed ID: 38531229 [TBL] [Abstract][Full Text] [Related]
9. Generation of an induced pluripotent stem cell line (SDASi001-A) from a Schimke immune-osseous dysplasia patient with SMARCAL1 mutations. Wang X; Zhang H; Wang X; Zhou W; Dong L; Li N; He Q Stem Cell Res; 2023 Oct; 72():103217. PubMed ID: 37788557 [TBL] [Abstract][Full Text] [Related]
10. Generation of an induced pluripotent stem cell line SDPHi002-A from a patient with lung cancer. Ai D; Yang X; Li X; Liu N; Xie X; Liu Y; Song W Stem Cell Res; 2023 Jun; 69():103096. PubMed ID: 37104933 [TBL] [Abstract][Full Text] [Related]
11. Generation of an induced pluripotent stem cell line, FJMUUHi001-A, from a hereditary Parkinson's disease patient with homozygous mutation of c.189dupA in PARK7. Chen ZT; Zhao ZH; Chen LN; Fan F; Cai GE; Weng HD; Wang YQ; Liao LM; Chen XC; Huang E; Ye QY Stem Cell Res; 2021 Mar; 51():102175. PubMed ID: 33485186 [TBL] [Abstract][Full Text] [Related]
12. Robust and highly efficient hiPSC generation from patient non-mobilized peripheral blood-derived CD34 Okumura T; Horie Y; Lai CY; Lin HT; Shoda H; Natsumoto B; Fujio K; Kumaki E; Okano T; Ono S; Tanita K; Morio T; Kanegane H; Hasegawa H; Mizoguchi F; Kawahata K; Kohsaka H; Moritake H; Nunoi H; Waki H; Tamaru SI; Sasako T; Yamauchi T; Kadowaki T; Tanaka H; Kitanaka S; Nishimura K; Ohtaka M; Nakanishi M; Otsu M Stem Cell Res Ther; 2019 Jun; 10(1):185. PubMed ID: 31234949 [TBL] [Abstract][Full Text] [Related]
13. Generation and characterisation of a human induced pluripotent stem cell line, NIMHi007-A, from peripheral blood mononuclear cells derived from an adult healthy female. Nimonkar MM; Arunachal G; Dash SS; Kandy SK; Raghavendra K; Chetan GK; Mehta B; Markandeya YS Stem Cell Res; 2023 Aug; 70():103130. PubMed ID: 37269666 [TBL] [Abstract][Full Text] [Related]
14. Generation of iPSC lines from peripheral blood mononuclear cells from five healthy donors. Vlahos K; Sourris K; Yi Kuah J; Graham A; Suter A; Howden SE; Stanley EG; Elefanty AG Stem Cell Res; 2023 Jun; 69():103109. PubMed ID: 37150143 [TBL] [Abstract][Full Text] [Related]
15. Generation of an erythroid progenitor-derived iPSC line, VRISGi002-A, from a healthy 27-year-old Vietnamese donor under a feeder-free system. Nhung Nguyen TH; Trinh Tran TT; Luong TH; Nguyen XH Stem Cell Res; 2022 Jul; 62():102824. PubMed ID: 35679757 [TBL] [Abstract][Full Text] [Related]
16. Establishment of PLAFMCi004-A induced pluripotent stem cells derived from PBMCs from a healthy individual. Shang S; Chen K; Cai G; Bai X; Chen X; Li Q Stem Cell Res; 2021 May; 53():102316. PubMed ID: 33878710 [TBL] [Abstract][Full Text] [Related]
17. Generation and characterization of the iPS cell line (SYSUSHi001-A) derived from the peripheral blood mononuclear cells (PBMCs) of a 33-year-old patient with acute myeloid leukemia (AML). Yuan L; Xie M; Tao Y; Chen X; Xu X; Wang X Stem Cell Res; 2024 Jun; 77():103360. PubMed ID: 38608356 [TBL] [Abstract][Full Text] [Related]
18. Establishment of induced pluripotent stem cell line SDPHi003-A from a healthy male donor. Xi Y; Zhang H; Yang X; Ai D; Liu Y; Song W Stem Cell Res; 2023 Sep; 71():103160. PubMed ID: 37429069 [TBL] [Abstract][Full Text] [Related]
19. Efficient generation of induced pluripotent stem cell lines from healthy donors' peripheral blood mononuclear cells of different genders. Gao Y; Cheng Y; Lin B; Xiao D; Wen J; Xu J; Zheng R; Zhang M; Cai C; Hu J Stem Cell Res; 2024 Jun; 77():103421. PubMed ID: 38636268 [TBL] [Abstract][Full Text] [Related]
20. Generation of an induced pluripotent stem cell line (GWCMCi005-A) from a patient with Lennox-Gastaut syndrome carrying TANC2 Gln1441Ter mutation. Tian Y; Shi Z; Liao Y; Cai J; Li W; Li X; Chen WX Stem Cell Res; 2022 Apr; 60():102667. PubMed ID: 35066241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]